Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction

J Med Chem. 2006 Jun 15;49(12):3432-5. doi: 10.1021/jm051122a.

Ke Ding ¹, Yipin Lu, Zaneta Nikolovska-Coleska, Guoping Wang, Su Qiu, Sanjeev Shangary, Wei Gao, Dongguang Qin, Jeanne Stuckey, Krzysztof Krajewski, Peter P Roller, Shaomeng Wang

Affiliations

Affiliation

1 Department of Internal Medicine, Comprehensive Cancer Center, Life Sciences Institute, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, 48109, USA.

PMID: 16759082 DOI: 10.1021/jm051122a

Abstract

Potent, specific, non-peptide small-molecule inhibitors of the MDM2-p53 interaction were successfully designed. The most potent inhibitor (MI-63) has a K(i) value of 3 nM binding to MDM2 and greater than 10,000-fold selectivity over Bcl-2/Bcl-xL proteins. MI-63 is highly effective in activation of p53 function and in inhibition of cell growth in Cancer cells with wild-type p53 status. MI-63 has excellent specificity over Cancer cells with deleted p53 and shows a minimal toxicity to normal cells.

Name
Email *

	Sorry, but the email address you supplied was invalid.